Literature DB >> 27438321

Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals.

Jason D Roberts1, Donglei Hu2, Susan R Heckbert3, Alvaro Alonso4, Thomas A Dewland1, Eric Vittinghoff5, Yongmei Liu6, Bruce M Psaty7, Jeffrey E Olgin1, Jared W Magnani8, Scott Huntsman2, Esteban G Burchard9, Dan E Arking10, Kirsten Bibbins-Domingo11, Tamara B Harris12, Marco V Perez13, Elad Ziv2, Gregory M Marcus1.   

Abstract

IMPORTANCE: White persons have a higher risk of atrial fibrillation (AF) compared with black individuals despite a lower prevalence of risk factors. This difference may be due, at least in part, to genetic factors.
OBJECTIVES: To determine whether 9 single-nucleotide polymorphisms (SNPs) associated with AF account for this paradoxical differential racial risk for AF and to use admixture mapping to search genome-wide for loci that may account for this phenomenon. DESIGN, SETTING, AND PARTICIPANTS: Genome-wide admixture analysis and candidate SNP study involving 3 population-based cohort studies that were initiated between 1987 and 1997, including the Cardiovascular Health Study (CHS) (n = 4173), the Atherosclerosis Risk in Communities (ARIC) (n = 12 341) study, and the Health, Aging, and Body Composition (Health ABC) (n = 1015) study. In all 3 studies, race was self-identified. Cox proportional hazards regression models and the proportion of treatment effect method were used to determine the impact of 9 AF-risk SNPs among participants from CHS and the ARIC study. The present study began July 1, 2012, and was completed in 2015. MAIN OUTCOMES AND MEASURES: Incident AF systematically ascertained using clinic visit electrocardiograms, hospital discharge diagnosis codes, death certificates, and Medicare claims data.
RESULTS: A single SNP, rs10824026 (chromosome 10: position 73661450), was found to significantly mediate the higher risk for AF in white participants compared with black participants in CHS (11.4%; 95% CI, 2.9%-29.9%) and ARIC (31.7%; 95% CI, 16.0%-53.0%). Admixture mapping was performed in a meta-analysis of black participants within CHS (n = 811), ARIC (n = 3112), and Health ABC (n = 1015). No loci that reached the prespecified statistical threshold for genome-wide significance were identified. CONCLUSIONS AND RELEVANCE: The rs10824026 SNP on chromosome 10q22 mediates a modest proportion of the increased risk of AF among white individuals compared with black individuals, potentially through an effect on gene expression levels of MYOZ1. No additional genetic variants accounting for a significant portion of the differential racial risk of AF were identified with genome-wide admixture mapping, suggesting that additional genetic or environmental influences beyond single SNPs in isolation may account for the paradoxical racial risk of AF among white individuals and black individuals.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438321      PMCID: PMC5395094          DOI: 10.1001/jamacardio.2016.1185

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  39 in total

1.  A linear complexity phasing method for thousands of genomes.

Authors:  Olivier Delaneau; Jonathan Marchini; Jean-François Zagury
Journal:  Nat Methods       Date:  2011-12-04       Impact factor: 28.547

2.  Fast and accurate inference of local ancestry in Latino populations.

Authors:  Yael Baran; Bogdan Pasaniuc; Sriram Sankararaman; Dara G Torgerson; Christopher Gignoux; Celeste Eng; William Rodriguez-Cintron; Rocio Chapela; Jean G Ford; Pedro C Avila; Jose Rodriguez-Santana; Esteban Gonzàlez Burchard; Eran Halperin
Journal:  Bioinformatics       Date:  2012-04-11       Impact factor: 6.937

3.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  European ancestry as a risk factor for atrial fibrillation in African Americans.

Authors:  Gregory M Marcus; Alvaro Alonso; Carmen A Peralta; Guillaume Lettre; Eric Vittinghoff; Steven A Lubitz; Ervin R Fox; Yamini S Levitzky; Reena Mehra; Kathleen F Kerr; Rajat Deo; Nona Sotoodehnia; Meggie Akylbekova; Patrick T Ellinor; Dina N Paltoo; Elsayed Z Soliman; Emelia J Benjamin; Susan R Heckbert
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

5.  Characterizing the admixed African ancestry of African Americans.

Authors:  Fouad Zakharia; Analabha Basu; Devin Absher; Themistocles L Assimes; Alan S Go; Mark A Hlatky; Carlos Iribarren; Joshua W Knowles; Jun Li; Balasubramanian Narasimhan; Steven Sidney; Audrey Southwick; Richard M Myers; Thomas Quertermous; Neil Risch; Hua Tang
Journal:  Genome Biol       Date:  2009-12-22       Impact factor: 13.583

6.  Common variants in KCNN3 are associated with lone atrial fibrillation.

Authors:  Patrick T Ellinor; Kathryn L Lunetta; Nicole L Glazer; Arne Pfeufer; Alvaro Alonso; Mina K Chung; Moritz F Sinner; Paul I W de Bakker; Martina Mueller; Steven A Lubitz; Ervin Fox; Dawood Darbar; Nicholas L Smith; Jonathan D Smith; Renate B Schnabel; Elsayed Z Soliman; Kenneth M Rice; David R Van Wagoner; Britt-M Beckmann; Charlotte van Noord; Ke Wang; Georg B Ehret; Jerome I Rotter; Stanley L Hazen; Gerhard Steinbeck; Albert V Smith; Lenore J Launer; Tamara B Harris; Seiko Makino; Mari Nelis; David J Milan; Siegfried Perz; Tõnu Esko; Anna Köttgen; Susanne Moebus; Christopher Newton-Cheh; Man Li; Stefan Möhlenkamp; Thomas J Wang; W H Linda Kao; Ramachandran S Vasan; Markus M Nöthen; Calum A MacRae; Bruno H Ch Stricker; Albert Hofman; André G Uitterlinden; Daniel Levy; Eric Boerwinkle; Andres Metspalu; Eric J Topol; Aravinda Chakravarti; Vilmundur Gudnason; Bruce M Psaty; Dan M Roden; Thomas Meitinger; H-Erich Wichmann; Jacqueline C M Witteman; John Barnard; Dan E Arking; Emelia J Benjamin; Susan R Heckbert; Stefan Kääb
Journal:  Nat Genet       Date:  2010-02-21       Impact factor: 38.330

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Incident atrial fibrillation among Asians, Hispanics, blacks, and whites.

Authors:  Thomas A Dewland; Jeffrey E Olgin; Eric Vittinghoff; Gregory M Marcus
Journal:  Circulation       Date:  2013-10-08       Impact factor: 29.690

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

View more
  12 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Atrial fibrillation: Puzzling out the race paradox.

Authors:  Dario Ummarino
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

3.  A study of the clinical application value of ultrasound and electrocardiogram in the differential diagnosis of cardiomyopathy.

Authors:  Yanyan Zhao; Shibin Lin; Jingjing Wu; Jineng Lai; Lan Li
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Symptom challenges after atrial fibrillation ablation.

Authors:  Kathryn A Wood; Angel H Barnes; Sudeshna Paul; Kristina A Hines; Kevin P Jackson
Journal:  Heart Lung       Date:  2017-09-18       Impact factor: 2.210

5.  Genetic Risk Scores for Atrial Fibrillation: Do They Improve Risk Estimation?

Authors:  Henry D Huang; Dawood Darbar
Journal:  Can J Cardiol       Date:  2016-12-14       Impact factor: 5.223

Review 6.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Authors:  Laila Staerk; Jason A Sherer; Darae Ko; Emelia J Benjamin; Robert H Helm
Journal:  Circ Res       Date:  2017-04-28       Impact factor: 17.367

7.  Validation of a genetic risk score for atrial fibrillation: A prospective multicenter cohort study.

Authors:  Evan D Muse; Nathan E Wineinger; Emily G Spencer; Melissa Peters; Riley Henderson; Yunyue Zhang; Paddy M Barrett; Steven P Rivera; Jay G Wohlgemuth; James J Devlin; Dov Shiffman; Eric J Topol
Journal:  PLoS Med       Date:  2018-03-13       Impact factor: 11.069

8.  Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation.

Authors:  Wesley T O'Neal; Aniqa B Alam; Pratik B Sandesara; J'Neka S Claxton; Richard F MacLehose; Lin Y Chen; Lindsay G S Bengtson; Alanna M Chamberlain; Faye L Norby; Pamela L Lutsey; Alvaro Alonso
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

9.  The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Laura R Loehr; Elsayed Z Soliman; Anna K Poon; David Couper; Lin Yee Chen; Thomas H Mosley; Lynne E Wagenknecht; Eric A Whitsel; Alvaro Alonso; Lisa Wruck; Gerardo Heiss
Journal:  Am Heart J       Date:  2019-07-03       Impact factor: 4.749

10.  Genetic heterogeneity of atrial fibrillation susceptibility loci across racial or ethnic groups.

Authors:  Henry Huang; Dawood Darbar
Journal:  Eur Heart J       Date:  2017-09-07       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.